Home Page ::: Current Drug Discovery Technologies

ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)


Volume 11, 4 Issues, 2014


Download PDF Flyer




Current Drug Discovery Technologies

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Vladimir P. Torchilin


Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

SCImago Journal Ranking

SCImago Journal & Country Rank

Endorsement(s)

"Modern drug discovery is increasingly driven by scientific integration, the ability to pull together seemingly unrelated branches of basic and applied sciences to produce in a timely fashion innovative and efficacious solutions to multidisciplinary human health problems. The editorial staff is to be congratulated for providing a superb forum for publishing such science and the many and varied new directions that challenge how we think about and address drug discovery."

Paul A. Wender
Stanford University, USA

Forthcoming Special Issue(s)

Development of Novel Agent targeting the Insulin and Insulin-like Growth Factor Receptor Pathways


Guest Editor(s): Antonio Gualberto
Tentative Publish Date: June, 2013
Submit Abstract via Email Download Description

Current Drug Discovery Technologies

,

Volume 11

-

Number 2



Selective Cyclooxygenase Inhibitors: Current Status

; Pp: 127 - 132

Ravindran Nandakishore, Prasanna R. Yalavarthi, Yengala R. Kiran and Malepati Rajapranathi


DOI: 10.2174/1570163811666140127123717
View Abstract Purchase Online Rights and Permissions

  
  



Design and Synthesis of New Potent Inhibitors of Farnesyl Pyrophosphate Synthase

; Pp: 133 - 144

Volodymyr Prokopenko, Vasyl Kovalishyn, Michael Shevchuk, Iryna Kopernyk, Larysa Metelytsia, Vadim Romanenko, Sergey Mogilevich and Valery Kukhar


DOI: 10.2174/15701638113106660041
View Abstract Purchase Online Rights and Permissions

  
  



In-Vitro Assessment and Pharmacodynamics of Nimesulide Incorporated Aloe vera Transemulgel

; Pp: 162 - 167

KR Vandana, Prasanna R. Yalavarthi, CR Sundaresan, Raghava N. Sriramaneni and Harini C. Vadlamudi


DOI: 10.2174/1570163810666131202233721
View Abstract Purchase Online Rights and Permissions

  
  



Cubosomes as Targeted Drug Delivery Systems - A Biopharmaceutical Approach


M Naga Lakshmi, Y Prasanna Raju, V Harini Chowdary, T Jyotsna, Y Gowri and K Haritha


View Abstract Purchase Online

  
  


Biofilm Formation by Candida Albicans is Inhibited by 4,4-Dichloro Diphenyl Diselenide (pCl-PhSe)2


Isabela Bueno Rossetia, Paulo Taube Juniorb, Claudia Barbosa Ladeira de Camposc, João Batista Teixeira da Rochad and Maricilia Silva Costaa


View Abstract

  
  


Formulation and Pharmacodynamic Evaluation of Glibenclamide Incorporated Niosomal Gel


Harini Chowdary, Y Prasanna Raju, Rao P Satyanarayana, K R Vandana, Jayasri Vulava and G Thulasi Chowdary


View Abstract

  
  


Deregulated Expression of Mir-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP


Guoqi Song, Guorong Song, Hunyun Ni, Ling Gu, William C. Cho, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan and Shukui Wang


View Abstract

  
  


Effects of Perfluorocarbon Dodecafluoropentane (NVX-108) on Cerebral Microvasculaturein the Healthy Rat


Paula F. Moon-Massat, Rania Abutarboush, Georgina Pappas, Ashraful Haque, Chioma Aligbe, Francoise Arnaud, Charles Auker, Richard McCarron and Anke Scultetus


View Abstract

  
  


Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap


Mohammad Zaki Ahmad, Shabib Akhter, Nehalz Mohsin and Basel Abdel-Wahab


View Abstract

  
  


Advertisement

Related Journals




Related eBooks




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science